A blood test that can accurately detect the presence of Alzheimer’s disease in the early stages is moving closer to reality because of the work by Dr. Robert Nagele and researchers at the Rowan University School of Osteopathic Medicine in New Jersey.
During the American Osteopathic Association’s OMED 15 conference in October, Dr. Nagele presented an update on the team’s research, which focuses on using autoantibodies to help identify the presence of Alzheimer’s before symptoms appear. By detecting the disease early, patients can make beneficial treatment choices and lifestyle changes, such as diet, exercise and managing blood pressure, to slow advancement of the disease. Dr. Nagele’s groundbreaking research is funded by OHF and the Michael J. Fox Foundation.
Learn more at: https://today.rowan.edu/